The Use of a Language Toolkit for Toddlers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Michael Steiner, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT00926510
First received: June 22, 2009
Last updated: October 10, 2011
Last verified: October 2011
  Purpose

To investigate whether young children with isolated expressive language delay benefit from early intervention with a simple language toolkit and brief instructions provided to their caregivers.

We hypothesize that children whose families are provided the language toolkit will develop more words over the subsequent 3 months.


Condition Intervention
Language Acquisition
Behavioral: Language toolkit
Behavioral: Safety counseling

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Two to Talk: The Use of a Language Toolkit for Toddlers

Resource links provided by NLM:


Further study details as provided by University of North Carolina, Chapel Hill:

Primary Outcome Measures:
  • Language/Words acquisition [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: August 2009
Study Completion Date: September 2011
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Language Toolkit
Language toolkit composed of simple tools that parents can use to interact with child and help language acquisition.
Behavioral: Language toolkit
Simple toolkit of interactive things to stimulate language.
Placebo Comparator: 2
Safety counseling and smoke detector
Behavioral: Safety counseling
Smoke detector and general safety counseling

  Eligibility

Ages Eligible for Study:   14 Months to 19 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age 14.5 to 18.5 months
  • Below average expressive language
  • Otherwise normal development

Exclusion Criteria:

  • Other developmental delay
  • Non-English primary language
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00926510

Locations
United States, North Carolina
North Carolina Children's Hospital
Chapel Hill, North Carolina, United States, 27516
Sponsors and Collaborators
University of North Carolina, Chapel Hill
Investigators
Study Director: Michael J Steiner, MD UNC Hospitals
Principal Investigator: Jennifer Hartz, MD UNC Hospitals
Principal Investigator: Mary Ann Cross, MD UNC Hospitals
Study Director: Karen L Wysocki, MS, M Ed UNC Hospitals
  More Information

No publications provided

Responsible Party: Michael Steiner, MD, Asst. Professor, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT00926510     History of Changes
Other Study ID Numbers: 09-0549
Study First Received: June 22, 2009
Last Updated: October 10, 2011
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on August 20, 2014